RYOAX Mutual Fund (Rydex Biotechnology Fund Class H) is managed by Rydex Funds with $5.4M in net assets. RYOAX expense ratio is 1.64%, holding 75 positions across sectors including Health Care, Unknown, Other. Inception date: 1998-04-01.

RYOAX performance shows a YTD return of 16.87%. The 1-year return is 80.23% and the 5-year return is 11.67%. RYOAX dividend yield stands at 13.62%, paid annually.

RYOAX top holdings include Abbvie Inc (7.4%), Amgen Inc. (5.2%), Gilead Sciences Inc (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). View all RYOAX holdings, sector breakdown, or dividend history.

RYOAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RYOAX alternatives are available via the screener, along with tax-loss harvesting opportunities.